質量分析を用いた低分子化合物の定量的解析法の構築とバイオマーカーに関する研究
スポンサーリンク
概要
- 論文の詳細を見る
Mass spectrometry-based quantitative analysis and biomarker discovery using metabolomics approach represent one of the major platforms in clinical fields including for the prognosis or diagnosis, assessment of severity and response to therapy in a number of clinical disease states as well as therapeutic drug monitoring (TDM). This review first summarizes our mass spectrometry-based research strategy and some results on relationship between cysteinyl leukotriene (cysLT), thromboxane (TX), 12-hydroxyeicosatetraenoic acid (12-HETE) and other metabolites of arachidonic acid and diseases such as atopic dermatitis, rheumatoid arthritis and diabetes mellitus. For the purpose of evaluating the role of these metabolites of arachidonic acid in disease status, we have developed sensitive determination methods with simple solid-phase extraction and applied in clinical settings. In addition to these endogenous compounds, using mass spectrometry, we have developed actually applicable quantitative methods for TDM. Representative example was a method of TDM for sirolimus, one of the immunosuppressant agents for a recipient of organ transplant, which requires rigorous monitoring of blood level. As we recognized great potential in mass spectrometry during these researches, we have become interested in metabolomics as the non-targeted analysis of metabolites. Now, established strategy for the metabolomics investigation applies to samples from cells, animals and humans to separate groups based on altered patterns of metabolites in biological fluids and to identify metabolites as potential biomarkers discriminating groups. We would be honored if our research using mass spectrometry would contribute to provide useful information in the field of medical pharmacy.
著者
関連論文
- P1-590 学生用実習ワークシートを活用するSP参加型実習の評価 : フィードバック内容の分析と今後の課題(一般演題 ポスター発表,薬学教育(その他),臨床から学び臨床へと還元する医療薬学)
- 質量分析を用いた低分子化合物の定量的解析法の構築とバイオマーカーに関する研究
- 土-P3-407 乳癌FEC100療法におけるホスアプレピタント注の有効性と安全性の検討(がん薬物療法(制吐支持療法),ポスター発表,一般演題,再興、再考、創ろう最高の医療の未来)